Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study - Concepedia

Concepedia

Publication | Open Access

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

DOI Full Paper Access

271

Citations

33

References

2009

Year

Ezra E.W. Cohen, Darren W. Davis, Theodore Karrison, Tanguy Y. Seiwert, Stuart J. Wong, Sreenivasa Nattam, Mark Kozloff, Joseph I. Clark, Duen‐Hwa Yan, Wen Liu,

The Lancet Oncology

Metastatic Squamous-cell CarcinomaMalignant DiseasePhase I/ii StudyMedicinePathologyHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer Research

References

	Year	Citations

Page 1

Page 1